Collaborations, Competitor News, Data Partnership

TARGET-IBD Study Reveals Nearly a Third of Patients with Inflammatory Bowel Disease Did Not Undergo Objective Assessment Prior to Biologic Dose Change, Discontinuation

Posted on

DURHAM, N.C., March 8, 2022 /PRNewswire/ — A new TARGET-IBD study analysis shows one-third of patients with inflammatory bowel disease (IBD) did not have a record of objective disease activity assessment or therapeutic drug monitoring (TDM) prior to a biologic therapy dose change or discontinuation. The study was conducted by Target RWE, a leading…

Competitor News, Oncology, Product Updates

Exscientia to Highlight Precision Medicine Platform and Pipeline Data at the American Association of Cancer Research Annual Meeting 2022

Posted on

AI-driven discovery platform enables new way to find novel pathways as well as progress towards identifying patients who may better respond to drugs in the clinic Preclinical data highlights the potential benefits of Exscientia’s AI-driven design to rapidly discover molecules with optimised properties, including GTAEXS-617 March 08, 2022 04:30 PM…

AI, Collaborations, Competitor News, Data Partnership

Cognito Therapeutics and Aetion Announce Partnership to Use Artificial Intelligence to Identify Rapidly Progressing Forms of Mild Cognitive Impairment and Alzheimer’s Disease

Posted on

March 08, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, and Aetion, a global real-world evidence (RWE) technology and analytics provider, today announced a strategic partnership to develop a validated predictive model to identify patients with…

Competitor News, COVID-19, Product Updates

Truveta announces new COVID-19 insights and unveils Truveta platform for the first time at #ViVE2022

Posted on

TUESDAY MARCH 8TH, 2022 Those without boosters nearly two times more likely to get COVID-19 during Omicron surge, with greater risk for those with co-morbidities BELLEVUE, Wash.– March 8, 2022 – Truveta, the health system-led company with a vision of saving lives with data, unveiled the Truveta platform in its…

Partner and Collaborator News

MITRE JOINS CAPITAL FACTORY’S INNOVATION COUNCIL TO ADVANCE TECHNOLOGY SOLUTIONS FOR THE FEDERAL GOVERNMENT

Posted on

Austin, Tx., McLean, Va., & Bedford, Mass., March 8, 2022—MITRE has joined Capital Factory’s Innovation Council (IC), which connects the world’s largest companies with the most innovative startups across Texas. MITRE will support the startup ecosystem with its deep technology and engineering expertise – collaborating and convening with other corporate and government innovators…

Competitor News, Fundraising/IPO

DNAnexus Secures $200 Million Funding Led by Blackstone Growth to Advance its Biomedical Data-Driven Technology Platform for Precision Medicine

Posted on

March 08, 2022 08:45 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data…

Academic, Competitor News, Europe, International, RWE Study

Advancing digital health applications: priorities for innovation in real-world evidence generation

Posted on

Ariel D Stern 1, Jan Brönneke 2, Jörg F Debatin 2, Julia Hagen 2, Henrik Matthies 2, Smit Patel 3, Ieuan Clay 4, Bjoern Eskofier 5, Annika Herr 6, Kurt Hoeller 7, Ashley Jaksa 8, Daniel B Kramer 9, Mattias Kyhlstedt 10, Katherine T Lofgren 11, Nirosha Mahendraratnam 12, Holger Muehlan 13, Simon Reif 14, Lars Riedemann 15, Jennifer C Goldsack 3 Affiliations 1Technology and Operations Management Unit, Harvard Business School, Boston, MA, USA; Health Innovation Hub, Berlin Germany; Digital Health Center, Hasso-Plattner Institute, Potsdam, Germany. Electronic…

Industry News, RWE Study

Exploiting real-world data to monitor physical activity in patients with osteoarthritis: the opportunity of digital epidemiology

Posted on

Abstract Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. Current guidelines emphasize the importance of regular physical activity as a preventive measure against disease progression and as a valuable strategy for pain and functionality management. Despite this, most patients with osteoarthritis are inactive. Modern technological advances…

Collaborations, Competitor News, Data Partnership

Racial disparities in outcomes of arthroscopic rotator cuff repair: A propensity score matched analysis using multiple national data sets

Posted on

ABSTRACT BACKGROUND: Disparities in access, utilization and outcomes exist throughout the healthcare system for minority groups, including racial and ethnic minorities; these disparities have wide-reaching implications for individuals as well as the healthcare system as a whole. This study will examine the impact of race on short and medium term…

Industry News, RWE Study

Real-World Data Describe Eribulin Efficacy After Novel Agents for MBC

Posted on

Treatment with eribulin (Halaven) elicited an estimated 2-year overall survival (OS) rate of 53.6% (95% CI, 35.1%-68.9%) for patients with metastatic breast cancer (MBC) previously treated with atezolizumab (Tecentriq) or sacituzumab govitecan (Trodelvy), according to real-world findings presented as a poster at the 39th Annual Miami Breast Cancer Conference®. “The treatment landscape…